📅 PUBMED DAILY TRIAGE — 2026-11-04 Window: 2026-11-03T10:16:06Z → 2026-11-04T10:22:30Z (CRDT) Topics scanned: 10 | Articles reviewed: 119 | Candidates evaluated: 130 High priority: 6 | Standard: 29 | Low/archive: 0 | Unsolicited finds: 1 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): No high-priority finds today (best candidate scored 6/10)
CBC-based diagnostics and machine learning in hematology
CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10)
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
pubmed:42975929 · Rising cell-free DNA level tracks cancer-associated methylation signal and improves multicancer detection. · 8/10 · It also has a practical implication: we show that rising ccfDNA concentration is associated with higher cancer detection sensitivity, even within disease stages and particularly in early-stage disease-stage I sensitivity varied from 0;55 in the lowest ccfDNA concentration tertile to 0;85 in the highest, and stage II from 0;59 to 0;86
AI/ML in clinical diagnostics and imaging
pubmed:42977647 · Can artificial intelligence add diagnostic value for human readers in detecting coronary artery stenosis on coronary CT angiography? A Bayesian network meta-analysis. · 8/10 · AI assistance improved sensitivity most clearly for less-experienced readers
Precision oncology and genomic medicine
Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 7/10)
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 6/10)
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: No high-priority finds today (best candidate scored 5/10)
Aging, longevity, and population health
pubmed:42974671 · Risk factors for cognitive impairment in patients undergoing hemodialysis: an umbrella review and meta-analysis. · 8/10 · Cognitive impairment and cognitive frailty are associated with multiple demographic, clinical, and dialysis-related factors but represent distinct outcomes that should be interpreted separately pubmed:42975900 · Spousal Traumatic Brain Injury and Risk of Mortality, Dementia, and Cardiovascular Events. · 8/10 · These findings suggest that the consequences of TBI may extend beyond injured individuals and support family- and care partner-centered approaches to care pubmed:42976199 · Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study. · 8/10 · Findings support prioritizing broader sociodemographic development alongside educational attainment and healthy lifestyles, with potential policy approaches including income and social protection, housing improvements, access to health care, and prevention
Rare diseases with high unmet need
pubmed:42977486 · PCR hyper-automation: an example of spinal muscular atrophy and severe combined immunodeficiency screening. · 8/10 · The study indicates the efficiency of this system as a first-tier NBS assay enabling the early, pre-symptomatic detection of SMA and SCID
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
pubmed:42974694 · Lysine-Targeted Covalent Inhibition of eIF4E with an Anionic Electrophile Warhead. · 6/10 · Drug Development pubmed:42975088 · Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments. · 6/10 · Drug Development pubmed:42975627 · The "Pearl Sign": A conventional MRI feature for distinguishing brain metastasis from glioblastoma and primary CNS lymphoma. · 6/10 · Diagnostics pubmed:42975681 · SPINK2 knockdown reduces proliferation and promotes cell death in MLL-MLLT3-rearranged THP-1 cells. · 5/10 · Drug Development
CBC-based diagnostics and machine learning in hematology
No retained standard-priority finds today.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
pubmed:42975309 · Clinical utility of Circulating Long Non-Coding RNAs in indeterminate thyroid nodules. · 7/10 · Early Detection pubmed:42975193 · Ultrasensitive ctDNA Assay Lowers the Detection Floor in Esophageal Cancer. · 6/10 · Early Detection pubmed:42976635 · Poly(adenosine diphosphate-ribose) polymerase-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional homologous recombination-deficient testing. · 5/10 · Diagnostics
AI/ML in clinical diagnostics and imaging
pubmed:42976340 · Integration of an FDA-Authorized Digital Autism Diagnostic Tool Into an Outpatient Developmental Pediatrics Workflow: Preliminary Quality Improvement Study. · 6/10 · Diagnostics pubmed:42977189 · 18F-FDG PET-based radiomics for the prediction of aggressive/high-grade tumor in patients with cartilaginous tumors: A preliminary study. · 5/10 · Diagnostics pubmed:42977358 · Artificial Intelligence-Driven Diagnosis, Endotyping and Risk Stratification in Obstructive Sleep Apnea. · 5/10 · Diagnostics
Precision oncology and genomic medicine
pubmed:42976417 · Prognostic value of PD-L1 expression and association with HRD in high-grade serous ovarian cancer: an ancillary analysis of the PAOLA-1/ENGOT-ov25 trial (GINECO). · 7/10 · Genomics/Precision Medicine pubmed:42975120 · Co-targeting PARP and SHP2 Overcomes Resistance to Apoptosis and Induces Durable Responses in Breast Cancer. · 5/10 · Drug Development pubmed:42977101 · Reprogramming the tumor microbiome: Opportunities for cancer prevention, diagnosis, and precision therapy. · 5/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
pubmed:42975930 · Rapid target engagement of KRAS G12C tricomplex inhibitor RO3903 overcomes resistance and drives durable tumor regression. · 6/10 · Drug Development pubmed:42975942 · Engineered T cell-agonist chimera for logic-gated STING activation and augmented cancer immunotherapy. · 6/10 · Treatment Innovation pubmed:42975943 · Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy. · 6/10 · Treatment Innovation pubmed:42977101 · Reprogramming the tumor microbiome: Opportunities for cancer prevention, diagnosis, and precision therapy. · 5/10 · Genomics/Precision Medicine pubmed:42977217 · A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆. · 5/10 · Drug Development
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
pubmed:42975136 · Bexagliflozin: pharmacological profile and clinical applications of a sodium-glucose cotransporter 2 inhibitor. · 5/10 · Treatment Innovation pubmed:42977436 · AMPK activation and urea cycle enhancement mediate the protective effect of dietary leucine restriction in nonalcoholic fatty liver disease. · 4/10 · Prevention pubmed:42977454 · Polyphenol-starch complex regulates the butyric acid-NXPH4-PDX1 pathway and alters pancreatic α- and β-cell marker expression profiles via the gut microbiota to stabilize postprandial blood glucose levels in mice with type 2 diabetes. · 4/10 · Prevention
Aging, longevity, and population health
pubmed:42975933 · Epigenetic aging during the COVID-19 pandemic: A prospective longitudinal study with prepandemic baseline data in children, adolescents, and adults. · 7/10 · Public Health pubmed:42976219 · Sex and educational inequalities across functional ability trajectories in Chile: A sequence analysis of a 17-year national panel. · 7/10 · Public Health pubmed:42975943 · Senescent CD8 T effector memory cells are functionally impaired, enriched in aging and disease, and a barrier to immunotherapy. · 6/10 · Treatment Innovation pubmed:42977480 · The Relationships Among Joy of Life, Social Support, and Life Satisfaction in Individuals Aged 55 and Older: The Mediating Role of Psychological Well-Being. · 5/10 · Public Health
Rare diseases with high unmet need
pubmed:42974700 · Phase 1 Evaluation of the Pharmacokinetics of Sevasemten (EDG-5506) for Potential Food Effect and Drug-Drug Interaction With a CYP3A4 Moderate Inhibitor. · 6/10 · Drug Development pubmed:42974838 · Pain in rare disorders. · 5/10 · Public Health pubmed:42976863 · An SMN2 splicing-correcting antisense oligonucleotide promotes gene looping and transcription activation. · 5/10 · Drug Development pubmed:42977270 · A Novel Deep-Intronic Variant in HES7 Unveils a Poison Exon Mechanism Underlying Spondylocostal Dysostosis. · 4/10 · Genomics/Precision Medicine pubmed:42977535 · Intron Retention Caused by a Novel Homozygous LNPK Splice-Site Variant Leading to Severe Neurodevelopmental Disorder and Epilepsy. · 4/10 · Genomics/Precision Medicine
💡 UNSOLICITED FINDS
pubmed:42973207 · Prevalence and factors associated with intrapartum and immediate postpartum obstetric complications in Ethiopia: a secondary analysis of a national longitudinal survey. · 7/10 · Pregnancy complications and prolonged labour were associated with a higher prevalence of immediate postpartum complications, while health-facility childbirth was associated with a lower prevalence
📊 TODAY’S BREAKDOWN
- By research category: Diagnostics 6, Drug Development 8, Early Detection 4, Genomics/Precision Medicine 4, Prevention 2, Public Health 8, Treatment Innovation 3
- By evidence maturity: Exploratory 20, Validated 15
- By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 4 kept / highest 6
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 15 reviewed / 4 kept / highest 8
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 4 kept / highest 8
- Precision oncology and genomic medicine: 15 reviewed / 3 kept / highest 7
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 5 kept / highest 6
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 3 kept / highest 5
- Aging, longevity, and population health: 15 reviewed / 7 kept / highest 8
- Rare diseases with high unmet need: 15 reviewed / 6 kept / highest 8
- Sentinel scan: 10 reviewed / 1 kept / highest 7
- By source type: peer_reviewed 35 | preprint 0
- Topics with zero 8+ articles this run: Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma), CBC-based diagnostics and machine learning in hematology, Precision oncology and genomic medicine, Novel therapeutics: immunotherapy, CAR-T, targeted therapy, Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
🔧 RUN NOTES
- T2 returned zero candidates for both primary and configured fallback queries; coverage is complete.
- Raw results exceeded caps in most topics; accepted candidates were limited to 15 per watchlist topic and 10 for sentinel.
- All 119 unique candidates were reconciled against both ESummary and EFetch.
- No Telegram alert was sent by this attempt; rerun alert duplicates remain suppressed.